Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Menopause | 38 | 2024 | 1640 | 4.220 |
Why?
|
Sexual Dysfunction, Physiological | 14 | 2024 | 357 | 3.100 |
Why?
|
Sexual Dysfunctions, Psychological | 16 | 2022 | 189 | 2.600 |
Why?
|
Postmenopause | 20 | 2020 | 2509 | 2.080 |
Why?
|
Sexuality | 6 | 2023 | 170 | 1.900 |
Why?
|
Estrogen Replacement Therapy | 18 | 2023 | 1206 | 1.830 |
Why?
|
Estrogens | 17 | 2023 | 1520 | 1.560 |
Why?
|
Hot Flashes | 14 | 2024 | 328 | 1.450 |
Why?
|
Testosterone | 16 | 2015 | 2470 | 1.390 |
Why?
|
Sexual Behavior | 15 | 2023 | 2086 | 1.290 |
Why?
|
Androgens | 10 | 2017 | 1291 | 1.180 |
Why?
|
Libido | 9 | 2015 | 119 | 1.110 |
Why?
|
Hormone Replacement Therapy | 12 | 2023 | 755 | 1.060 |
Why?
|
Estradiol | 15 | 2019 | 1932 | 1.030 |
Why?
|
Menopause, Premature | 4 | 2022 | 125 | 1.020 |
Why?
|
Ovariectomy | 6 | 2007 | 611 | 0.930 |
Why?
|
Vaginal Diseases | 3 | 2021 | 103 | 0.870 |
Why?
|
Estrogens, Conjugated (USP) | 5 | 2018 | 275 | 0.850 |
Why?
|
Women's Health | 7 | 2018 | 2056 | 0.540 |
Why?
|
Vulva | 3 | 2019 | 82 | 0.470 |
Why?
|
Administration, Cutaneous | 10 | 2008 | 713 | 0.440 |
Why?
|
Atrophy | 6 | 2020 | 1627 | 0.400 |
Why?
|
Perimenopause | 6 | 2018 | 141 | 0.390 |
Why?
|
Endothelial Growth Factors | 5 | 2000 | 673 | 0.380 |
Why?
|
Lymphokines | 5 | 2000 | 927 | 0.360 |
Why?
|
Endocrine Glands | 2 | 2010 | 101 | 0.350 |
Why?
|
Dyspareunia | 3 | 2019 | 48 | 0.350 |
Why?
|
Vagina | 7 | 2020 | 837 | 0.350 |
Why?
|
Cyclohexanols | 3 | 2015 | 126 | 0.350 |
Why?
|
Endometrium | 8 | 2004 | 403 | 0.330 |
Why?
|
Female | 99 | 2024 | 391270 | 0.330 |
Why?
|
Administration, Intravaginal | 6 | 2019 | 151 | 0.310 |
Why?
|
Menstrual Cycle | 6 | 2022 | 536 | 0.290 |
Why?
|
Climacteric | 2 | 2003 | 57 | 0.280 |
Why?
|
Psychometrics | 1 | 2016 | 3051 | 0.270 |
Why?
|
Societies, Medical | 3 | 2015 | 3905 | 0.270 |
Why?
|
Vaginal Smears | 1 | 2008 | 495 | 0.250 |
Why?
|
Endometrial Neoplasms | 4 | 2022 | 1357 | 0.240 |
Why?
|
Humans | 101 | 2024 | 760621 | 0.230 |
Why?
|
Middle Aged | 48 | 2024 | 220352 | 0.230 |
Why?
|
Ovary | 4 | 2005 | 958 | 0.220 |
Why?
|
Progesterone | 1 | 2007 | 742 | 0.220 |
Why?
|
HIV Wasting Syndrome | 1 | 2003 | 97 | 0.210 |
Why?
|
Depressive Disorder | 4 | 2018 | 3726 | 0.210 |
Why?
|
Physical Examination | 1 | 2008 | 1244 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 4 | 2012 | 3164 | 0.200 |
Why?
|
Vasomotor System | 3 | 2024 | 207 | 0.200 |
Why?
|
Personal Satisfaction | 3 | 2012 | 643 | 0.200 |
Why?
|
Quality of Life | 12 | 2024 | 13308 | 0.200 |
Why?
|
Dehydroepiandrosterone | 2 | 2018 | 257 | 0.200 |
Why?
|
Mood Disorders | 1 | 2008 | 1124 | 0.200 |
Why?
|
Aromatase Inhibitors | 1 | 2006 | 511 | 0.200 |
Why?
|
Thromboembolism | 1 | 2008 | 1017 | 0.190 |
Why?
|
Anti-Mullerian Hormone | 1 | 2024 | 407 | 0.190 |
Why?
|
Hysterectomy | 4 | 2005 | 904 | 0.180 |
Why?
|
Administration, Oral | 5 | 2018 | 4035 | 0.180 |
Why?
|
Gonadal Steroid Hormones | 3 | 2018 | 701 | 0.180 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2019 | 62 | 0.170 |
Why?
|
Embryonic and Fetal Development | 3 | 1998 | 420 | 0.170 |
Why?
|
Preoperative Care | 1 | 2008 | 2256 | 0.160 |
Why?
|
Neovascularization, Physiologic | 4 | 2004 | 1336 | 0.160 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2315 | 0.160 |
Why?
|
Lubricants | 1 | 2018 | 26 | 0.160 |
Why?
|
Patient Selection | 2 | 2008 | 4283 | 0.160 |
Why?
|
Methyltestosterone | 3 | 2004 | 19 | 0.160 |
Why?
|
Sweating | 1 | 2019 | 154 | 0.150 |
Why?
|
Affect | 2 | 2003 | 1480 | 0.150 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2018 | 132 | 0.150 |
Why?
|
Adrenal Cortex | 1 | 1998 | 134 | 0.150 |
Why?
|
Cross-Over Studies | 5 | 2008 | 2061 | 0.140 |
Why?
|
Infertility | 2 | 2023 | 655 | 0.140 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2000 | 155 | 0.140 |
Why?
|
Adult | 44 | 2024 | 219994 | 0.140 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21025 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 518 | 0.130 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1998 | 618 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3839 | 0.130 |
Why?
|
Citalopram | 2 | 2012 | 402 | 0.120 |
Why?
|
Translating | 1 | 2016 | 148 | 0.120 |
Why?
|
Mind-Body Relations, Metaphysical | 1 | 2014 | 36 | 0.120 |
Why?
|
Infertility, Female | 2 | 2014 | 759 | 0.120 |
Why?
|
Double-Blind Method | 12 | 2019 | 12427 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 536 | 0.120 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2015 | 146 | 0.120 |
Why?
|
Endometriosis | 3 | 1998 | 874 | 0.120 |
Why?
|
North America | 2 | 2014 | 1284 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 1998 | 4433 | 0.110 |
Why?
|
Tamoxifen | 1 | 2018 | 963 | 0.110 |
Why?
|
Product Labeling | 1 | 2014 | 77 | 0.110 |
Why?
|
Attitude | 1 | 2019 | 777 | 0.110 |
Why?
|
Receptor, IGF Type 2 | 1 | 1993 | 35 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2008 | 7475 | 0.110 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2010 | 377 | 0.110 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2008 | 546 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 5 | 2000 | 748 | 0.110 |
Why?
|
Self Report | 3 | 2022 | 3711 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1242 | 0.100 |
Why?
|
Laser Therapy | 1 | 2018 | 1089 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 2014 | 410 | 0.090 |
Why?
|
Research | 2 | 2018 | 1974 | 0.090 |
Why?
|
Fertilization in Vitro | 4 | 2001 | 1292 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 1993 | 380 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4538 | 0.090 |
Why?
|
Health Surveys | 3 | 2009 | 4063 | 0.090 |
Why?
|
Estrogen Antagonists | 2 | 2003 | 151 | 0.090 |
Why?
|
Consensus | 4 | 2024 | 3113 | 0.080 |
Why?
|
Premenopause | 2 | 2004 | 1038 | 0.080 |
Why?
|
Muscles | 1 | 1994 | 1581 | 0.080 |
Why?
|
Receptor, Insulin | 1 | 1993 | 836 | 0.080 |
Why?
|
Uterus | 1 | 1993 | 651 | 0.080 |
Why?
|
Nurses | 1 | 2018 | 2467 | 0.080 |
Why?
|
Pregnancy | 12 | 2024 | 29749 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2021 | 65017 | 0.080 |
Why?
|
Stress, Psychological | 3 | 2014 | 4446 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10344 | 0.080 |
Why?
|
Aged | 15 | 2019 | 169152 | 0.070 |
Why?
|
Orgasm | 3 | 2014 | 61 | 0.070 |
Why?
|
Information Services | 1 | 2009 | 235 | 0.070 |
Why?
|
Mental Disorders | 1 | 2007 | 6796 | 0.070 |
Why?
|
Transferrin | 1 | 2008 | 284 | 0.070 |
Why?
|
Fetus | 1 | 1994 | 1859 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 393 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2014 | 1803 | 0.070 |
Why?
|
Risk Factors | 9 | 2022 | 74359 | 0.070 |
Why?
|
Prealbumin | 1 | 2008 | 222 | 0.070 |
Why?
|
Prospective Studies | 9 | 2024 | 54303 | 0.070 |
Why?
|
United States | 12 | 2018 | 72461 | 0.070 |
Why?
|
Age Distribution | 2 | 2009 | 2893 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2018 | 1693 | 0.060 |
Why?
|
Expert Testimony | 1 | 2008 | 361 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 4 | 2001 | 725 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2004 | 3484 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 691 | 0.060 |
Why?
|
Health Services | 1 | 2010 | 753 | 0.060 |
Why?
|
Gene Expression | 2 | 1997 | 7588 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1079 | 0.060 |
Why?
|
Age Factors | 5 | 2024 | 18416 | 0.060 |
Why?
|
Levonorgestrel | 1 | 2004 | 74 | 0.060 |
Why?
|
Sex Counseling | 1 | 2004 | 17 | 0.060 |
Why?
|
Uterine Hemorrhage | 2 | 2004 | 242 | 0.060 |
Why?
|
Embryo Transfer | 2 | 1999 | 522 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 1126 | 0.060 |
Why?
|
Acupuncture Therapy | 1 | 2008 | 480 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3696 | 0.060 |
Why?
|
Thyroxine | 1 | 2007 | 667 | 0.060 |
Why?
|
Female Urogenital Diseases | 1 | 2024 | 57 | 0.060 |
Why?
|
Ointments | 1 | 2003 | 58 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 25942 | 0.060 |
Why?
|
Contraceptive Agents, Female | 1 | 2004 | 118 | 0.060 |
Why?
|
Drug Implants | 1 | 2004 | 230 | 0.060 |
Why?
|
Arousal | 2 | 2012 | 1157 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 24123 | 0.050 |
Why?
|
Semen | 1 | 2006 | 346 | 0.050 |
Why?
|
Gynecology | 1 | 2009 | 528 | 0.050 |
Why?
|
Coronary Disease | 1 | 2018 | 5990 | 0.050 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2004 | 276 | 0.050 |
Why?
|
Gels | 1 | 2004 | 419 | 0.050 |
Why?
|
HIV Infections | 3 | 2018 | 17165 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2010 | 1341 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2004 | 553 | 0.050 |
Why?
|
Infertility, Male | 1 | 2006 | 396 | 0.050 |
Why?
|
Prevalence | 5 | 2012 | 15687 | 0.050 |
Why?
|
Health Promotion | 1 | 2014 | 2206 | 0.050 |
Why?
|
Women | 1 | 2004 | 225 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.050 |
Why?
|
Endocrine System Diseases | 1 | 2004 | 250 | 0.050 |
Why?
|
Heart Arrest | 1 | 1992 | 1506 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15757 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14495 | 0.050 |
Why?
|
Ovarian Hyperstimulation Syndrome | 2 | 1999 | 47 | 0.050 |
Why?
|
Depression | 4 | 2022 | 8044 | 0.050 |
Why?
|
Spermatozoa | 1 | 2006 | 631 | 0.050 |
Why?
|
Hormones | 2 | 2020 | 867 | 0.050 |
Why?
|
Nitriles | 1 | 2006 | 956 | 0.050 |
Why?
|
Testosterone Congeners | 1 | 2001 | 61 | 0.050 |
Why?
|
Personality Inventory | 1 | 2003 | 1018 | 0.040 |
Why?
|
Triazoles | 1 | 2006 | 904 | 0.040 |
Why?
|
Laparoscopy | 1 | 1992 | 2147 | 0.040 |
Why?
|
Amenorrhea | 1 | 2023 | 480 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2001 | 244 | 0.040 |
Why?
|
Body Mass Index | 3 | 2022 | 12914 | 0.040 |
Why?
|
Parity | 1 | 2022 | 925 | 0.040 |
Why?
|
Antidepressive Agents | 3 | 2009 | 2890 | 0.040 |
Why?
|
Primary Health Care | 3 | 2012 | 4647 | 0.040 |
Why?
|
Patient Satisfaction | 3 | 2024 | 3448 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4751 | 0.040 |
Why?
|
Drug Interactions | 1 | 2003 | 1428 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2003 | 6015 | 0.040 |
Why?
|
Progestins | 1 | 2000 | 302 | 0.040 |
Why?
|
Ovarian Cysts | 1 | 1999 | 108 | 0.040 |
Why?
|
Pregnancy Rate | 2 | 1999 | 649 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3215 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 8056 | 0.040 |
Why?
|
Diethylstilbestrol | 1 | 1997 | 88 | 0.040 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1997 | 52 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11891 | 0.040 |
Why?
|
Adolescent | 5 | 2022 | 87810 | 0.040 |
Why?
|
Ovulation | 1 | 1998 | 181 | 0.040 |
Why?
|
Aging | 4 | 2020 | 8651 | 0.040 |
Why?
|
Surgical Procedures, Operative | 1 | 2008 | 1913 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2000 | 18957 | 0.030 |
Why?
|
Health Status | 4 | 2012 | 4081 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 2003 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 1993 | 11903 | 0.030 |
Why?
|
Genitalia, Female | 1 | 1995 | 147 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1997 | 554 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13981 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2007 | 4938 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1998 | 673 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2003 | 6498 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10827 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2005 | 3301 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14660 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2000 | 12766 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2009 | 15840 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1993 | 852 | 0.030 |
Why?
|
Lubrication | 1 | 2012 | 21 | 0.030 |
Why?
|
Young Adult | 2 | 2009 | 58741 | 0.030 |
Why?
|
Pregnancy Outcome | 2 | 2001 | 2907 | 0.020 |
Why?
|
Patient Preference | 1 | 2019 | 922 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 4878 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3301 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4744 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 778 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1994 | 1705 | 0.020 |
Why?
|
Pilot Projects | 3 | 2014 | 8555 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1407 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
Attention | 1 | 2001 | 2387 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1994 | 2262 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9716 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58995 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1894 | 0.020 |
Why?
|
Epithelium | 1 | 1994 | 1605 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2210 | 0.020 |
Why?
|
Piperidines | 1 | 1998 | 1650 | 0.020 |
Why?
|
Placenta Diseases | 1 | 1991 | 196 | 0.020 |
Why?
|
Marital Status | 1 | 2010 | 433 | 0.020 |
Why?
|
Immune System | 1 | 1994 | 798 | 0.020 |
Why?
|
Psychology | 1 | 2010 | 355 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2012 | 810 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1575 | 0.020 |
Why?
|
Cytokines | 2 | 2000 | 7343 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2515 | 0.020 |
Why?
|
Mammaplasty | 1 | 1998 | 1240 | 0.020 |
Why?
|
Patient Compliance | 1 | 2018 | 2688 | 0.020 |
Why?
|
Placenta Accreta | 1 | 1991 | 237 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2008 | 15697 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1677 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 1997 | 2640 | 0.020 |
Why?
|
Income | 1 | 2015 | 1875 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2773 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9631 | 0.020 |
Why?
|
Comorbidity | 2 | 2012 | 10551 | 0.020 |
Why?
|
Mental Health | 1 | 2000 | 3213 | 0.020 |
Why?
|
Embryo Implantation | 2 | 1998 | 270 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2496 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1997 | 4490 | 0.020 |
Why?
|
Registries | 2 | 2012 | 8469 | 0.020 |
Why?
|
Sperm Motility | 1 | 2006 | 265 | 0.010 |
Why?
|
Placebo Effect | 1 | 2008 | 520 | 0.010 |
Why?
|
Lipodystrophy | 1 | 2005 | 148 | 0.010 |
Why?
|
Gestational Age | 1 | 1993 | 3565 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2628 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9287 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6068 | 0.010 |
Why?
|
Menstruation | 1 | 2005 | 307 | 0.010 |
Why?
|
Stromal Cells | 2 | 2000 | 1326 | 0.010 |
Why?
|
Ohio | 1 | 2004 | 333 | 0.010 |
Why?
|
Pessaries | 1 | 2003 | 15 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12159 | 0.010 |
Why?
|
Social Class | 1 | 2012 | 2005 | 0.010 |
Why?
|
Regression Analysis | 2 | 2005 | 6360 | 0.010 |
Why?
|
Macrophages | 1 | 1997 | 5745 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12965 | 0.010 |
Why?
|
Thorax | 1 | 2005 | 553 | 0.010 |
Why?
|
Base Sequence | 1 | 1993 | 12446 | 0.010 |
Why?
|
Retrospective Studies | 5 | 2022 | 80372 | 0.010 |
Why?
|
Self-Assessment | 1 | 2004 | 393 | 0.010 |
Why?
|
Esterification | 1 | 2001 | 39 | 0.010 |
Why?
|
Apoptosis | 1 | 1997 | 9501 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2002 | 240 | 0.010 |
Why?
|
Decision Making | 1 | 2015 | 3925 | 0.010 |
Why?
|
Reproduction | 1 | 2005 | 646 | 0.010 |
Why?
|
Anthropometry | 1 | 2005 | 1348 | 0.010 |
Why?
|
Animals | 2 | 2018 | 167963 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17624 | 0.010 |
Why?
|
Ultrasonography | 2 | 2005 | 5961 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41335 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12922 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21392 | 0.010 |
Why?
|
DNA | 1 | 1993 | 7233 | 0.010 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2000 | 190 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2004 | 11071 | 0.010 |
Why?
|
Health Priorities | 1 | 2002 | 374 | 0.010 |
Why?
|
Ovulation Induction | 1 | 2001 | 277 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 1999 | 158 | 0.010 |
Why?
|
Menotropins | 1 | 1998 | 41 | 0.010 |
Why?
|
International Cooperation | 1 | 2004 | 1433 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1998 | 326 | 0.010 |
Why?
|
Lipectomy | 1 | 1998 | 112 | 0.010 |
Why?
|
Male | 5 | 2006 | 359744 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 1249 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 1997 | 282 | 0.010 |
Why?
|
Body Composition | 1 | 2005 | 2419 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6180 | 0.010 |
Why?
|
Prolactin | 1 | 1998 | 621 | 0.010 |
Why?
|
bcl-X Protein | 1 | 1997 | 413 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 1998 | 457 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1543 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 1998 | 820 | 0.010 |
Why?
|
Logistic Models | 2 | 2001 | 13314 | 0.010 |
Why?
|
Cell Polarity | 1 | 1998 | 638 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 666 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2000 | 1153 | 0.010 |
Why?
|
Child | 1 | 2022 | 79806 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4899 | 0.010 |
Why?
|
Random Allocation | 1 | 1998 | 2394 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39261 | 0.010 |
Why?
|
Suture Techniques | 1 | 1998 | 790 | 0.010 |
Why?
|
Oocytes | 1 | 1998 | 1165 | 0.010 |
Why?
|
Bone Density | 1 | 2005 | 3534 | 0.010 |
Why?
|
Motor Activity | 1 | 2001 | 2687 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8803 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1613 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5039 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4491 | 0.010 |
Why?
|
Biopsy | 1 | 2000 | 6771 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 2001 | 7021 | 0.000 |
Why?
|
Cognition | 1 | 2004 | 6957 | 0.000 |
Why?
|
Placenta | 1 | 1995 | 1702 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1998 | 3663 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15289 | 0.000 |
Why?
|
Cesarean Section | 1 | 1991 | 1385 | 0.000 |
Why?
|
Time Factors | 1 | 2001 | 40165 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1991 | 26181 | 0.000 |
Why?
|